Skip to content

Arcutis Biotherapeutics, Inc. ARQT Common Stock Shares Issued

Common Stock Shares Issued at other companies

Arcus Biosciences logo
Arcus BiosciencesRCUS
125.5M+18.5%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
20M+3.9%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
50.2M+34.0%
Bausch + Lomb logo
Bausch + LombBLCO
356.4M+0.9%
Incyte logo
IncyteINCY
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$105.4M+60.1%
Gross profit$95.6M+67.7%
Operating income-$9.1M+62.9%
Net income-$11.3M+54.9%
EPS (diluted)-$0.09+55.0%

Balance sheet

See full
Cash & equivalents$35.1M-34.7%
Total debt$114.7M+3.5%
Total equity$189.6M+32.9%
Total assets$460.0M+33.7%

Cash flow

See full
Operating cash flow$2.2M+107%
CapEx--100%
Free cash flow$2.2M+107%

Valuation

See full
Market cap$3.29B+57.5%

Profitability

See full
Gross margin90.9%+2.5pp
Operating margin-12%-5.7pp
Net margin-13.9%-6.6pp
FCF margin-52.5%-21.9pp

Returns & leverage

See full
Return on equity-28.2%-13.0pp
Debt / equity0.6×-0.2×
Current ratio2.7×-0.9×

Where this comes from

Reported directly by Arcutis Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcutis Biotherapeutics, Inc.'s common stock shares issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arcutis Biotherapeutics, Inc.'s common stock shares issued?
Arcutis Biotherapeutics, Inc. (ARQT) reported common stock shares issued of 125M in Q1 2026.
How has Arcutis Biotherapeutics, Inc.'s common stock shares issued changed year-over-year?
Arcutis Biotherapeutics, Inc.'s common stock shares issued increased by 5.0% year-over-year, from 119.1M to 125M.
What is the long-term trend for Arcutis Biotherapeutics, Inc.'s common stock shares issued?
Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s common stock shares issued has grown at a 23.1% compound annual growth rate (CAGR), from 43.7M to 123.3M.
What does common stock shares issued mean?
The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.